BR0211489A - Cristal de derivado de ariletenossulfonamida e processo de preparação do mesmo - Google Patents
Cristal de derivado de ariletenossulfonamida e processo de preparação do mesmoInfo
- Publication number
- BR0211489A BR0211489A BR0211489-5A BR0211489A BR0211489A BR 0211489 A BR0211489 A BR 0211489A BR 0211489 A BR0211489 A BR 0211489A BR 0211489 A BR0211489 A BR 0211489A
- Authority
- BR
- Brazil
- Prior art keywords
- ariletenesulfonamide
- preparing
- pyrimidin
- derivative crystal
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"CRISTAL DE DERIVADO DE ARILETENOSSULFONAMIDA E PROCESSO DE PREPARAçãO DO MESMO". A presente invenção refere-se a cristais de um sal potássico de (E)-N-[6-metóxi-5-(2-metoxifenóxi)-2-(pirimidin-2-il)pirimidin-4-il]-2-fenil ete-nossulfonamida, um processo de preparação dos mesmos, e novos solvatos de (E)-N-[6-metóxi-5-(2-etoxifenóxi)-2-(pirimidin-2-il)pirimidin-4-il]-2-fenilet e-nossulfonamida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001227253 | 2001-07-27 | ||
PCT/JP2002/007551 WO2003010152A1 (fr) | 2001-07-27 | 2002-07-25 | Nouveau cristal de derive d'arylethenesulfonamide et son procede de production |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0211489A true BR0211489A (pt) | 2004-08-17 |
Family
ID=19059947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0211489-5A BR0211489A (pt) | 2001-07-27 | 2002-07-25 | Cristal de derivado de ariletenossulfonamida e processo de preparação do mesmo |
Country Status (14)
Country | Link |
---|---|
US (1) | US7232904B2 (pt) |
EP (1) | EP1413578A4 (pt) |
JP (1) | JPWO2003010152A1 (pt) |
KR (1) | KR100757701B1 (pt) |
CN (1) | CN1245389C (pt) |
BR (1) | BR0211489A (pt) |
CA (1) | CA2452253C (pt) |
HU (1) | HUP0400869A3 (pt) |
MX (1) | MXPA04000650A (pt) |
NO (1) | NO20040346L (pt) |
PL (1) | PL366889A1 (pt) |
RU (1) | RU2004105867A (pt) |
WO (1) | WO2003010152A1 (pt) |
ZA (1) | ZA200309902B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102004010207A1 (de) * | 2004-03-02 | 2005-09-15 | Aventis Pharma S.A. | Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate |
DE102004010194A1 (de) * | 2004-03-02 | 2005-10-13 | Aventis Pharma Deutschland Gmbh | 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln |
CA2602097A1 (en) * | 2005-03-22 | 2006-09-28 | Daiichi Sankyo Company, Limited | Process for producing carbapenem derivatives having 1-alkylpyrrolidine structure |
WO2006121151A1 (ja) * | 2005-05-13 | 2006-11-16 | Daiichi Sankyo Company, Limited | 1-メチルカルバペネム化合物の結晶 |
CN111689934B (zh) * | 2020-06-24 | 2022-08-02 | 郑州大学 | 14-脱羟-13-脱氢穿心莲内酯-12-磺酸钾的单晶体及制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE201202T1 (de) * | 1995-12-20 | 2001-06-15 | Yamanouchi Pharma Co Ltd | Arylethensulfonamid-derivate und diese enthaltende medikamente |
-
2002
- 2002-07-25 US US10/484,836 patent/US7232904B2/en not_active Expired - Fee Related
- 2002-07-25 KR KR1020047001114A patent/KR100757701B1/ko not_active IP Right Cessation
- 2002-07-25 JP JP2003515511A patent/JPWO2003010152A1/ja active Pending
- 2002-07-25 CA CA002452253A patent/CA2452253C/en not_active Expired - Fee Related
- 2002-07-25 EP EP02751685A patent/EP1413578A4/en not_active Withdrawn
- 2002-07-25 PL PL02366889A patent/PL366889A1/xx not_active Application Discontinuation
- 2002-07-25 RU RU2004105867/04A patent/RU2004105867A/ru not_active Application Discontinuation
- 2002-07-25 MX MXPA04000650A patent/MXPA04000650A/es not_active Application Discontinuation
- 2002-07-25 CN CNB028149556A patent/CN1245389C/zh not_active Expired - Fee Related
- 2002-07-25 BR BR0211489-5A patent/BR0211489A/pt not_active Application Discontinuation
- 2002-07-25 WO PCT/JP2002/007551 patent/WO2003010152A1/ja active Application Filing
- 2002-07-25 HU HU0400869A patent/HUP0400869A3/hu unknown
-
2003
- 2003-12-22 ZA ZA200309902A patent/ZA200309902B/en unknown
-
2004
- 2004-01-26 NO NO20040346A patent/NO20040346L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CA2452253C (en) | 2009-06-02 |
MXPA04000650A (es) | 2004-03-19 |
ZA200309902B (en) | 2005-03-14 |
HUP0400869A2 (hu) | 2004-07-28 |
RU2004105867A (ru) | 2005-06-27 |
KR20040018514A (ko) | 2004-03-03 |
WO2003010152A1 (fr) | 2003-02-06 |
NO20040346L (no) | 2004-03-24 |
PL366889A1 (en) | 2005-02-07 |
HUP0400869A3 (en) | 2004-10-28 |
EP1413578A4 (en) | 2004-10-20 |
JPWO2003010152A1 (ja) | 2004-11-18 |
US7232904B2 (en) | 2007-06-19 |
CN1535265A (zh) | 2004-10-06 |
CN1245389C (zh) | 2006-03-15 |
EP1413578A1 (en) | 2004-04-28 |
CA2452253A1 (en) | 2003-02-06 |
KR100757701B1 (ko) | 2007-09-14 |
US20040162302A1 (en) | 2004-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0215493A (pt) | Processo para preparação de ésteres escopìnicos | |
BR0111319A (pt) | Composto, processo para preparar um composto, uso de um composto, processo para preparar um sal de um composto, e, composto intermediário | |
BR0213380A (pt) | Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes | |
BR0307702A (pt) | Formulações de solução contendo anticorpo | |
AP1853A (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents. | |
BR0214469A (pt) | 17alfa-alquil-17beta-óxi-estratrienos e produtos intermediários para sua preparação, aplicação dos 17alfa-alquil-17beta-óxi-estratrienos para a preparação de medicamentos bem como preparações farmacêuticas | |
BR0114316A (pt) | Processo para a preparação de formulações em pó | |
BR0311984A (pt) | Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação | |
BR0301667A (pt) | Processo para a preparação de polìmeros em emulsão com pureza elevada | |
BR0211489A (pt) | Cristal de derivado de ariletenossulfonamida e processo de preparação do mesmo | |
BR0212772A (pt) | Processo para a preparação de repaglinida | |
HUP0002754A2 (hu) | (1S,4R)-cisz-4-[2-amino-6-(ciklopropil-amino)-9H-purin-9-il]-2-ciklopentén-1-metanol-hemiszulfát, eljárás előállítására, ezt tartalmazó gyógyszerkészítmény, valamint intermedierek | |
GT200000035AA (es) | Derivados de resorcinol, (solicitud fraccionaria no. 1 derivada de la patente pi-2000-0035) | |
BR0316702A (pt) | xprocesso para preparação de (s)-pantoprazol | |
MXPA04004621A (es) | Nucleotidos, preparaciones de los mismos y su utilizacion como inhibidores de polimerasas virales de arn. | |
HUP0400345A2 (hu) | Vírusellenes aktivitású foszfono-pirimidin-származékok | |
BR0212390A (pt) | Processo para a preparação de cilastatina | |
BR0011996A (pt) | Preparação de piperidin-4-onas substituìdas | |
DE60039631D1 (de) | Cyclopentyl sulfonamid derivaten | |
BR0212927A (pt) | Formas pseudopolimórficas de carvedilol | |
BRPI0411245A (pt) | composto, composição farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de vìrus oncogênicos e para tratamento ou profilaxia de condições ou distúrbios devidos a infecção por hpv | |
BR9909260A (pt) | Processo para o preparo de (r)-alfa-(2,3-dimetóxifenil)-1-[2-(4-fluoro-fenil)etil]-4-pi peridinametanol | |
MXPA03008248A (es) | Agentes colorantes para fibras de queratina que contienen derivados de n-heteroarilmetil-m-fenilendiamina, asi como nuevos derivados de n-heteroarilmetil-m-fenilendiamina. | |
BR0116721A (pt) | Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina | |
HUP0302255A2 (hu) | Szulfonamidszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |